Free Trial

BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts

BioNTech logo
$92.77 -2.01 (-2.12%)
As of 05/9/2025 04:00 PM Eastern

BioNTech Earnings Summary

BioNTech released Q4 2024 earnings on March 10, 2025, reporting an EPS of $1.08, which beat the consensus estimate of $0.38 by $0.70. Quarterly revenue fell 19.5% year-over-year to $1.19 billion, below analysts' expectations of $1.24 billion. With a trailing EPS of -$3.40, BioNTech's earnings are expected to decrease next year, from ($3.88) to ($4.17) per share.

Latest Q4
Earnings Date
Mar. 10Estimated
Consensus EPS
(Mar. 10)
$0.38
Actual EPS
(Mar. 10)
$1.08 Beat By $0.70
Actual Revenue
(Mar. 10)
$1.19B

Q4 2024 Earnings Resources

Get BioNTech Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNTech and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioNTech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20252-$5.78-$2.34-$4.06
Q2 20252-$2.70-$2.52-$2.61
Q3 20252-$1.23-$0.79-$1.01
Q4 20252$0.07$0.58$0.33

BioNTech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/10/2025Q4 2024$0.38$1.08+$0.70$1.15$1.24B$1.19B
11/4/2024Q3 2024-$1.26$0.81+$2.07$0.89$514.08M$1.24B
8/5/2024Q2 2024-$2.02-$3.36 -$1.34-$3.62$134.98M$128.70M
5/6/2024Q1 2024-$0.82-$1.42 -$0.60-$1.42$589.96M$203.69M
3/20/2024Q4 2023$2.64$2.05 -$0.59$2.05$2.04B$1.59B
11/6/2023Q3 2023-$0.59$0.67+$1.26$0.73$850.50M$895.30M
8/7/2023Q2 2023-$0.83-$0.79+$0.04-$0.86$628.13M$167.70M

BioNTech Earnings - Frequently Asked Questions

BioNTech (NASDAQ:BNTX) last announced its quarterly earning data on Monday, March 10, 2025. Learn more on BNTX's earnings history.

BioNTech issued an update on its FY 2025 earnings guidance on Monday, May, 5th. The company issued revenue guidance of $1.8 billion-$2.3 billion, compared to the consensus revenue estimate of $2.1 billion.

In the previous quarter, BioNTech (NASDAQ:BNTX) reported $1.08 earnings per share (EPS) to beat the analysts' consensus estimate of $0.38 by $0.70. Learn more on analysts' earnings estimate vs. BNTX's actual earnings.

The conference call for BioNTech's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BioNTech's latest earnings report can be read online.
Read Transcript

BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $2.75 billion.

BioNTech (NASDAQ:BNTX) has a recorded net income of $1.01 billion. BNTX has generated -$3.40 earnings per share over the last four quarters.

BioNTech's earnings are expected to decrease from ($3.88) per share to ($4.17) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BNTX) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners